Ir.bausch.com

Investor Relations Bausch + Lomb Corporation

WEBBausch + Lomb Corporation (NYSE/TSX: BLCO) is a leading global eye health company that is dedicated to protecting and enhancing the gift of sight for millions of people …

Actived: 2 days ago

URL: https://ir.bausch.com/

Bausch + Lomb Receives FDA Approval for TENEO™ Excimer Laser …

WEBVAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people …

Category: Health Go Health

4Q23 & FY23 Financial Results

WEBThe guidance in this presentation is only effective as of the date given, Feb. 21, 2024. Distribution or reference of this deck following Feb. 21, 2024 does not constitute the …

Category: Health Go Health

Bausch + Lomb to Participate in the 42nd Annual J.P. Morgan …

WEBBausch + Lomb to Participate in the 42nd Annual J.P. Morgan Healthcare Conference Jan 03 2024. VAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb …

Category: Health Go Health

2Q22 Financial Results

WEBto health care products and services resulting from a possible resurgence of the virus and variant and subvariant strains thereof on a global basis in 2022; there will be increased …

Category: Health Go Health

3Q23 Financial Results

WEBBausch + Lomb Approach. Multi-factorial disease, requires different treatment options. Large ~$1.7B U.S. market1, DED affects more than 38M Americans2. Underdiagnosed …

Category: Health Go Health

4Q22 & FY22 Financial Results

WEB3. Adjusted cash flow from operations (non-GAAP) is Cash flow from operations, its most closely associated GAAP measure, less separation and separation-related payments of …

Category: Health Go Health

Bausch + Lomb Announces Second-Quarter 2022 Results

WEBVision Care segment revenues were $589 million for the second quarter of 2022, as compared to $556 million for the second quarter of 2021, an increase of $33 …

Category: Health Go Health

Bausch + Lomb Publishes Update Presentation for the 41st Annual …

WEBBausch + Lomb Publishes Update Presentation for the 41st Annual J.P. Morgan Healthcare Conference Jan 09 2023. VAUGHAN, Ontario--(BUSINESS WIRE)- …

Category: Health Go Health

Bausch + Lomb and Novaliq Announce U.S. FDA Filing Acceptance …

WEBPDUFA Action Date is June 28, 2023. VAUGHAN, Ontario and HEIDELBERG, Germany, Sept. 6, 2022 /PRNewswire/ -- Bausch + Lomb Corporation …

Category: Health Go Health

J.P. Morgan Healthcare Conference

WEBGlobal leader in consumer eye health, outpacing U.S. market growth by ~1.7x since 20184. The most integrated eye care company1. 80+% of world population has …

Category: Health Go Health

Bausch + Lomb Will Release Fourth-Quarter and Full-Year 2023 …

WEBVAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people …

Category: Health Go Health

1Q23 Financial Results

WEBThis is a non-GAAP measure or ratio. See Slide 1 and Appendix for further information on non-GAAP measures and ratios. 3. Includes transactional FX and NCI. Currency …

Category: Health Go Health

Bausch + Lomb Will Acquire XIIDRA®

WEBBausch + Lomb Will Acquire XIIDRA® Jun 30 2023. Acquisition Represents Significant Opportunity for Growth in Prescription Dry Eye Segment. VAUGHAN, Ontario …

Category: Health Go Health

Bausch + Lomb Announces First-Quarter 2024 Results

WEBVision Care Segment Vision Care segment revenue was $635 million for the first quarter of 2024, as compared to $587 million for the first quarter of 2023, an …

Category: Health Go Health

1Q22 Financial Results

WEBBausch Health Companies Inc. (“BHC”) and the timing of the completion of such spin off, the anticipated opportunities of the Company as a standalone entity (including the …

Category: Health Go Health

1Q24 Financial Results

WEBBausch + Lomb undertakes no obligation to update any of these forward-looking statements to reflect events or circumstances after the date of this presentation or to reflect actual …

Category: Health Go Health

Bausch + Lomb Completes Acquisition of XIIDRA®

WEBVAUGHAN, Ontario -- (BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people …

Category: Health Go Health

Bausch + Lomb Announces U.S. Launch of StableVisc

WEBVAUGHAN, Ontario--(BUSINESS WIRE)--Bausch + Lomb Corporation (NYSE/TSX: BLCO) (“Bausch + Lomb”), a leading global eye health company dedicated …

Category: Health Go Health

Bausch + Lomb Receives Health Canada Approval of LUMIFY® …

WEB"With Health Canada's approval of LUMIFY ®, we are excited to be able to now offer Canadians a new option to help relieve their red, irritated eyes," said Joe …

Category: Health Go Health

Bausch + Lomb Corporation Announces Pricing of IPO

WEBBausch Health develops, manufactures and markets a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, …

Category: Medical Go Health

Bausch + Lomb and Glaucoma Research Foundation Launch Faces …

WEBThroughout the month of January, Bausch + Lomb and GRF will share educational resources and patient stories to empower individuals to take care of their …

Category: Health Go Health